Xindi Qian

Strategies of engineering nanomedicines for tumor retention.

Yaping Li, Zhiwen Zhang, Jingyuan Wen, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer

Ying Cai, Dangge Wang, Xindi Qian, 2022, Acta Pharmacologica Sinica.

Microvesicle-inspired oxygen-delivering nanosystem potentiates radiotherapy-mediated modulation of tumor stroma and antitumor immunity.

Yaping Li, Zhiwen Zhang, Jie Li, 2022, Biomaterials.

Poly(maleic anhydride-alt-1-octadecene)-based bioadhesive nanovehicles improve oral bioavailability of poor water-soluble gefitinib

M. Zhang, Yaping Li, Zhiwen Zhang, 2022, Drug development and industrial pharmacy.

ROS-Responsive Nanocomplex of aPD-L1 and Cabazitaxel Improves Intratumor Delivery and Potentiates Radiation-Mediated Antitumor Immunity.

Yaping Li, Zhiwen Zhang, Jie Li, 2022, Nano letters.

Spatial-Drug-Laden Protease-Activatable M1 Macrophage System Targets Lung Metastasis and Potentiates Antitumor Immunity.

Qianqian Wang, Yaping Li, Zhiwen Zhang, 2023, ACS nano.

Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy

Yaping Li, Zhiwen Zhang, Yuqi Wang, 2021, Advanced healthcare materials.

Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy.

Yaping Li, Zhiwen Zhang, Yuqi Wang, 2022, Journal of controlled release : official journal of the Controlled Release Society.